CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.
Read More…
Industry, Sector and Symbol
Industry Freight transportation arrangement
Sub-IndustryN/A
SectorTransportation
Phone949-470-2300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$19.63 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date3/5/2020 (Estimated)
OptionableOptionable
CryoPort (NASDAQ:CYRX) Frequently Asked Questions
What is CryoPort's stock symbol?
CryoPort trades on the NASDAQ under the ticker symbol "CYRX."
How were CryoPort's earnings last quarter?
CryoPort Inc (NASDAQ:CYRX) released its earnings results on Thursday, November, 7th. The consumer goods maker reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.02. The consumer goods maker earned $9.58 million during the quarter, compared to the consensus estimate of $9.49 million. CryoPort had a negative return on equity of 26.50% and a negative net margin of 64.63%. The firm's quarterly revenue was up 81.1% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.07) earnings per share. View CryoPort's Earnings History.
When is CryoPort's next earnings date?
What price target have analysts set for CYRX?
4 analysts have issued 1 year target prices for CryoPort's stock. Their forecasts range from $22.00 to $26.00. On average, they anticipate CryoPort's share price to reach $24.00 in the next year. This suggests a possible upside of 57.2% from the stock's current price. View Analyst Price Targets for CryoPort.
What is the consensus analysts' recommendation for CryoPort?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CryoPort.
Has CryoPort been receiving favorable news coverage?
Media stories about CYRX stock have trended neutral recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CryoPort earned a daily sentiment score of 0.3 on InfoTrie's scale. They also assigned media stories about the consumer goods maker a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for CryoPort.
Are investors shorting CryoPort?
CryoPort saw a drop in short interest during the month of October. As of October 15th, there was short interest totalling 6,220,000 shares, a drop of 13.6% from the September 15th total of 7,200,000 shares. Based on an average trading volume of 660,200 shares, the short-interest ratio is presently 9.4 days. Currently, 17.7% of the company's shares are short sold. View CryoPort's Current Options Chain.
Who are some of CryoPort's key competitors?
What other stocks do shareholders of CryoPort own?
Who are CryoPort's key executives?
CryoPort's management team includes the folowing people:
- Jerrell W. Shelton, Chairman, President & Chief Executive Officer
- Phil Wilson, SVP-Global Operations & Supply Chain
- Robert S. Stefanovich, Chief Financial Officer, Secretary & Treasurer
- Bret Bollinger, Chief Technology Officer
- Mark W. Sawicki, Chief Commercial Officer
Who are CryoPort's major shareholders?
CryoPort's stock is owned by many different of institutional and retail investors. Top institutional shareholders include TimesSquare Capital Management LLC (3.78%), Columbus Circle Investors (0.99%), Creative Planning (0.97%), Taylor Wealth Management Partners (0.83%), SG Capital Management LLC (0.70%) and Handelsbanken Fonder AB (0.51%). Company insiders that own CryoPort stock include Jerrell Shelton and Richard J Berman. View Institutional Ownership Trends for CryoPort.
Which major investors are selling CryoPort stock?
CYRX stock was sold by a variety of institutional investors in the last quarter, including Creative Planning, Perkins Capital Management Inc., Taylor Frigon Capital Management LLC, Essex Investment Management Co. LLC, D.A. Davidson & CO., Rice Hall James & Associates LLC, Taylor Wealth Management Partners and Conestoga Capital Advisors LLC. View Insider Buying and Selling for CryoPort.
Which major investors are buying CryoPort stock?
CYRX stock was purchased by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Columbus Circle Investors, SG Capital Management LLC, SG Americas Securities LLC, California Public Employees Retirement System, Handelsbanken Fonder AB, Cadence Capital Management LLC and Handelsinvest Investeringsforvaltning. View Insider Buying and Selling for CryoPort.
How do I buy shares of CryoPort?
Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is CryoPort's stock price today?
One share of CYRX stock can currently be purchased for approximately $15.27.
How big of a company is CryoPort?
CryoPort has a market capitalization of $547.34 million and generates $19.63 million in revenue each year. The consumer goods maker earns $-9,560,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. View Additional Information About CryoPort.
What is CryoPort's official website?
How can I contact CryoPort?
CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]
MarketBeat Community Rating for CryoPort (NASDAQ CYRX)
MarketBeat's community ratings are surveys of what our community members think about CryoPort and other stocks. Vote "Outperform" if you believe CYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
